低分子ヘパリンは、皮下注射による自己投与が可能であり、入院の必要性がないなどの大きな利点があります。また、未分画ヘパリンと比較して、より予測可能な活性を有し、血液モニタリングの必要がありません。さらに、低分子ヘパリンは胎盤を通過せず、胎児に害を与えないため、血栓のリスクが高い妊婦に有利です。低分子ヘパリン市場は、世界の血液疾患の発生率の増加やLMWH抗凝固療法の導入により、予測期間中に有利な成長を遂げると予想されます。
2019年のクリーブランドクリニック（Cleveland Clinic）によると、ヨーロッパとアメリカの白人の約50人に1人が血液関連障害に苦しんでいます。プロトロンビン遺伝子変異、第V因子ライデン、線溶系異常、フィブリノゲン値上昇または機能不全などです。また、2021年にStatistaによると、血友病と診断され、約80,302人がフォンウィルブランド病と診断されていました。未分画ヘパリン以上の低分子量ヘパリンの増加する利点と市場参入企業による成長および開発活動の上昇は、市場で有利な成長活動を作成する要因です。しかし、低分子量ヘパリンの副作用は、2022年から2029年の予測期間における市場の成長を阻害します。
世界の低分子ヘパリン市場調査のために考慮された主要な地域は、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、および世界のその他の地域が含まれています。北アメリカは、血液関連疾患の負担増加、老年人口の増加、製品承認数の増加などの要因により、市場を独占しています。また、北アメリカは、研究開発活動の活発化や未分画ヘパリンに対する低分子ヘパリンの認知度の向上などの要因から、最も高いCAGRで急成長している地域と見なされています。
本調査の目的は、近年における様々なセグメント・国の市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。
さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Low Molecular Heparin Market, by Region, 2019-2029 (USD Billion)
1.2.2. Low Molecular Heparin Market, by Product, 2019-2029 (USD Billion)
1.2.3. Low Molecular Heparin Market, by Application, 2019-2029 (USD Billion)
1.2.4. Low Molecular Heparin Market, by End User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Low Molecular Heparin Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Low Molecular Heparin Market Dynamics
3.1. Low Molecular Heparin Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of blood disorders globally
3.1.1.2. Introduction of LMWH anticoagulation
3.1.2. Market Challenges
3.1.2.1. Adverse effects of low molecular weight heparin
3.1.3. Market Opportunities
3.1.3.1. Increasing advantages of low molecular weight heparin over unfractionated heparin
3.1.3.2. Rising growth and development activities by market players
Chapter 4. Global Low Molecular Heparin Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Low Molecular Heparin Market, by Product
6.1. Market Snapshot
6.2. Global Low Molecular Heparin Market by Product, Performance - Potential Analysis
6.3. Global Low Molecular Heparin Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
6.4. Low Molecular Heparin Market, Sub-Segment Analysis
6.4.1. Enoxaparin
6.4.2. Dalteparin
6.4.3. Tinzaparin
6.4.4. Fondaparinux
6.4.5. Others
Chapter 7. Global Low Molecular Heparin Market, by Application
7.1. Market Snapshot
7.2. Global Low Molecular Heparin Market by Application, Performance - Potential Analysis
7.3. Global Low Molecular Heparin Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
7.4. Low Molecular Heparin Market, Sub-Segment Analysis
7.4.1. Deep Vein Thrombosis
7.4.2. Acute Coronary Syndrome (ACS)
7.4.3. Pulmonary Embolism
7.4.4. Other Applications
Chapter 8. Global Low Molecular Heparin Market, by End-User
8.1. Market Snapshot
8.2. Global Low Molecular Heparin Market by End-User, Performance - Potential Analysis
8.3. Global Low Molecular Heparin Market Estimates & Forecasts by End-User 2019-2029 (USD Billion)
8.4. Low Molecular Heparin Market, Sub-Segment Analysis
8.4.1. Hospitals and Clinics
8.4.2. Ambulatory Surgical Centres
8.4.3. Other End Users
Chapter 9. Global Low Molecular Heparin Market, Regional Analysis
9.1. Low Molecular Heparin Market, Regional Market Snapshot
9.2. North America Low Molecular Heparin Market
9.2.1. U.S. Low Molecular Heparin Market
9.2.1.1. Product breakdown estimates & forecasts, 2019-2029
9.2.1.2. Application breakdown estimates & forecasts, 2019-2029
9.2.1.3. End-User breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Low Molecular Heparin Market
9.3. Europe Low Molecular Heparin Market Snapshot
9.3.1. U.K. Low Molecular Heparin Market
9.3.2. Germany Low Molecular Heparin Market
9.3.3. France Low Molecular Heparin Market
9.3.4. Spain Low Molecular Heparin Market
9.3.5. Italy Low Molecular Heparin Market
9.3.6. Rest of Europe Low Molecular Heparin Market
9.4. Asia-Pacific Low Molecular Heparin Market Snapshot
9.4.1. China Low Molecular Heparin Market
9.4.2. India Low Molecular Heparin Market
9.4.3. Japan Low Molecular Heparin Market
9.4.4. Australia Low Molecular Heparin Market
9.4.5. South Korea Low Molecular Heparin Market
9.4.6. Rest of Asia Pacific Low Molecular Heparin Market
9.5. Latin America Low Molecular Heparin Market Snapshot
9.5.1. Brazil Low Molecular Heparin Market
9.5.2. Mexico Low Molecular Heparin Market
9.6. Rest of The World Low Molecular Heparin Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Pfizer, Inc.,
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. LEO Pharma A/S, Sanofi S.A.,
10.2.3. Teva Pharmaceutical Industries Ltd.,
10.2.4. Amphastar Pharmaceuticals Inc.,
10.2.5. Abbott Laboratories,
10.2.6. Aspen Pharmacare Holdings,
10.2.7. Laboratorios Farmaceuticos ROVI SA,
10.2.8. Changzhou Qianhong Biopharma,
10.2.9. Intrapharm Laboratories
10.2.10. Baxter International Inc.,
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Low Molecular Heparin Market, report scope
TABLE 2. Global Low Molecular Heparin Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Low Molecular Heparin Market estimates & forecasts by Product 2019-2029 (USD Billion)
TABLE 4. Global Low Molecular Heparin Market estimates & forecasts by Application 2019-2029 (USD Billion)
TABLE 5. Global Low Molecular Heparin Market estimates & forecasts by End-User 2019-2029 (USD Billion)
TABLE 6. Global Low Molecular Heparin Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Low Molecular Heparin Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Low Molecular Heparin Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Low Molecular Heparin Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Low Molecular Heparin Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Low Molecular Heparin Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Low Molecular Heparin Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Low Molecular Heparin Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Low Molecular Heparin Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Low Molecular Heparin Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Low Molecular Heparin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Low Molecular Heparin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Low Molecular Heparin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Low Molecular Heparin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Low Molecular Heparin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Low Molecular Heparin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Low Molecular Heparin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Low Molecular Heparin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Low Molecular Heparin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Low Molecular Heparin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Low Molecular Heparin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Low Molecular Heparin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Low Molecular Heparin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Low Molecular Heparin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Low Molecular Heparin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Low Molecular Heparin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Low Molecular Heparin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Low Molecular Heparin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Low Molecular Heparin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Low Molecular Heparin Market
TABLE 71. List of primary sources, used in the study of global Low Molecular Heparin Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Low Molecular Heparin Market, research methodology
FIG 2. Global Low Molecular Heparin Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Low Molecular Heparin Market, key trends 2021
FIG 5. Global Low Molecular Heparin Market, growth prospects 2022-2029
FIG 6. Global Low Molecular Heparin Market, porters 5 force model
FIG 7. Global Low Molecular Heparin Market, pest analysis
FIG 8. Global Low Molecular Heparin Market, value chain analysis
FIG 9. Global Low Molecular Heparin Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Low Molecular Heparin Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Low Molecular Heparin Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Low Molecular Heparin Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Low Molecular Heparin Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Low Molecular Heparin Market, regional snapshot 2019 & 2029
FIG 15. North America Low Molecular Heparin Market 2019 & 2029 (USD Billion)
FIG 16. Europe Low Molecular Heparin Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Low Molecular Heparin Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Low Molecular Heparin Market 2019 & 2029 (USD Billion)
FIG 19. Global Low Molecular Heparin Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
